Metabolium names chief operating officer and chief scientific director
Metabolium announces the appointment of Dr. Khadidja Romari as chief operating officer and chief scientific director.
Before joining the company, Romari spent several months as scientific advisor to Dominique Duvauchelle, CEO of Metabolium, to gain an understanding of the technologies developed by the company. Her new role will focus on developing Metabolium’s product portfolio and raising its international profile to secure new partnerships.
Dr. Romari has over twenty years experience in product development in the aquaculture, dietary supplements, cosmetic and pharmaceutical industries. Her expertise is in isolating, cultivating and valorizing cyanobacteria, microalgae, mushrooms and bacteria originating from varied environments.
Before joining Metabolium, Dr. Romari helped to develop American companies such as Bigelow Laboratory for Ocean Sciences, Albany Molecular Research and Targeted Growth.
Since returning to France in 2010 she has lead scientific and technical development at Fermentalg and then at Greensea. Dr. Romari has written close to 30 scientific publications and 16 patent families. She obtained a PhD in Process Engineering and Molecular Biology from the University of Montpellier II (France). Her academic path then led to the Institut Pasteur and the Roscoff National Centre for Scientific Research (CNRS).
Other news from the department people
Most read news
More news from our other portals
Last viewed contents
XOMA Appoints Steven B. Engle President, Chief Executive Officer and Director
Apitope Receives Orphan Designation in the European Union for ATX-F8-117 for the treatment of Haemophilia A
Amsterdam Molecular Therapeutics’ Glybera Significantly Reduces the Risk of Pancreatitis in LPLD Patients
Archimedes Pharma Enrols First Patient in Phase III Programme for Nasalfent in Cancer Pain
The virulence of the Toxoplasma parasite identified
